KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Short term Debt (2016 - 2025)

Historic Short term Debt for Amgen (AMGN) over the last 14 years, with Q3 2025 value amounting to $2.2 billion.

  • Amgen's Short term Debt fell 3924.94% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 3924.94%. This contributed to the annual value of $3.6 billion for FY2024, which is 14601.52% up from last year.
  • Per Amgen's latest filing, its Short term Debt stood at $2.2 billion for Q3 2025, which was down 3924.94% from $2.4 billion recorded in Q2 2025.
  • In the past 5 years, Amgen's Short term Debt registered a high of $5.5 billion during Q2 2024, and its lowest value of $87.0 million during Q4 2021.
  • For the 5-year period, Amgen's Short term Debt averaged around $2.4 billion, with its median value being $2.2 billion (2025).
  • Per our database at Business Quant, Amgen's Short term Debt soared by 465164.84% in 2021 and then tumbled by 8110.55% in 2022.
  • Over the past 5 years, Amgen's Short term Debt (Quarter) stood at $87.0 million in 2021, then skyrocketed by 1728.74% to $1.6 billion in 2022, then fell by 9.3% to $1.4 billion in 2023, then skyrocketed by 146.02% to $3.6 billion in 2024, then crashed by 39.35% to $2.2 billion in 2025.
  • Its Short term Debt stands at $2.2 billion for Q3 2025, versus $2.4 billion for Q2 2025 and $3.4 billion for Q1 2025.